Home / Import refusals / 799-6397288-2/10002/1

FDA Import Refusal 799-6397288-2/10002/1 — Novartis Pharma Gmbh

Novartis Pharma Gmbh — FEI 3002532211

The FDA refused shipment 799-6397288-2/10002/1 from Novartis Pharma Gmbh (Germany) on November 21, 2025. The refused product falls under Drugs and Biologics — OMALIZUMAB. Cited charges: 336,472,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
November 21, 2025
Country
Germany
Product Category
Drugs and Biologics
Product Code
58ACP04 OMALIZUMAB
Charges
336,472,75

Other import refusals

  • AEK-0005355-2/10002/1 (Mon Mar 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9480606-2/10002/1 (Wed Feb 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9195715-7/30002/1 (Thu Jan 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7507398-9/20002/1 (Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7507398-9/40001/1 (Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources